XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
12 Months Ended
Mar. 15, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Allocated share-based compensation expense (reversal)   $ 346.5 $ 338.0 $ 330.7
Income tax benefit, release of deferred tax asset valuation allowance     420.2 420.2
Corporate Headquarters Lease        
Gain on partial operating lease termination     158.8  
Cost of revenue        
Allocated share-based compensation expense (reversal)   22.9 23.3 24.7
Research and development        
Allocated share-based compensation expense (reversal) [1]   247.6 237.6 232.3
Research and development | President        
Allocated share-based compensation expense (reversal) $ (6.7)     4.4
Sales and marketing        
Allocated share-based compensation expense (reversal)   23.7 22.0 22.4
General and administrative        
Allocated share-based compensation expense (reversal)   $ 52.3 $ 55.1 $ 51.3
[1] On March 15, 2023, the former President resigned, resulting in the reversal of $6.7 million in stock-based compensation expense. Of the total amount reversed, $4.4 million related to expense recognized prior to January 1, 2023.